Halozyme Therapeutics Inc (NASDAQ:HALO)

35.70 Delayed Data As of 3:59pm ET	+1.21 / +3.51% Today’s Change	32.83 Today\|\|\|52-Week Range 59.46	-37.26% Year-to-Date

35.70

Delayed Data

As of 3:59pm ET

+1.21 / +3.51%

Today’s Change

32.83

Today|||52-Week Range

59.46

-37.26%

Year-to-Date

Halozyme Therapeutics (HALO) Down 34.4% Since Last Earnings Report: Can It Rebound? Mar 23 / Zacks.com - Paid Partner Content	Should You Invest in the SPDR S&P Biotech ETF (XBI)? Mar 16 / Zacks.com - Paid Partner Content
Strength Seen in Halozyme Therapeutics (HALO): Can Its 5.3% Jump Turn into More Strength? Mar 21 / Zacks.com - Paid Partner Content